Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster.
Recent findings indicate that elevated levels of glucocorticoids (GC), governed by the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) and GC receptors (GR), in visceral adipose tissue and skeletal muscle lead to increased insulin resistance and the metabolic syndrome. Paradoxically, evidence indicates that aerobic exercise attenuates the development of the metabolic syndrome even though it stimulates acute increases in circulating GC levels. To investigate the hypothesis that training alters peripheral GC action to maintain insulin sensitivity, young male hamsters were randomly divided into sedentary (S) and trained (T) groups (n = 8 in each). The T group had 24-h access to running wheels over 4 wk of study. In muscle, T hamsters had lower 11beta-HSD1 protein expression (19.2 +/- 1.40 vs. 22.2 +/- 0.96 optical density, P < 0.05), similar 11beta-HSD1 enzyme activity (0.9 +/- 0.27% vs. 1.1 +/- 0.26), and lower GR protein expression (9.7 +/- 1.86 vs. 15.1 +/- 1.78 optical density, P < 0.01) than S hamsters. In liver, 11beta-HSD1 protein expression tended to be lower in T compared with S (19.2 +/- 0.56 vs. 21.4 +/- 1.05, P = 0.07), whereas both enzyme activity and GR protein expression were similar. In contrast, visceral adipose tissue contained approximately 2.7-fold higher 11beta-HSD1 enzyme activity in T compared with S (12.9 +/- 3.3 vs. 4.8 +/- 1.5% conversion, P < 0.05) but was considerably smaller in mass (0.24 +/- 0.02 vs. 0.71 +/- 0.06 g). Thus the intracellular adaptation of GC regulators to exercise is tissue specific, resulting in decreases in GC action in skeletal muscle and increases in GC action in visceral fat. These adaptations may have important implications in explaining the protective effects of aerobic exercise on insulin resistance and other symptoms of the metabolic syndrome.
Coutinho
Agnes E
AE
Department of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Campbell
Jonathan E
JE
Fediuc
Sergiu
S
Riddell
Michael C
MC
D042842:11-beta-Hydroxysteroid Dehydrogenases / Q000096:biosynthesis / Q000502:physiology*; D000222:Adaptation, Physiological / Q000502:physiology; D000273:Adipose Tissue / Q000737:chemistry* / Q000502:physiology; D000818:Animals; D001786:Blood Glucose; D015992:Body Mass Index; D006224:Cricetinae; D004435:Eating; D005938:Glucocorticoids / Q000032:analysis / Q000097:blood / Q000502:physiology; D007328:Insulin; D007333:Insulin Resistance / Q000502:physiology; D050152:Intra-Abdominal Fat / Q000737:chemistry / Q000502:physiology; D008099:Liver / Q000737:chemistry / Q000502:physiology; D008297:Male; D008647:Mesocricetus; D024821:Metabolic Syndrome / Q000209:etiology / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000737:chemistry* / Q000502:physiology; D010805:Physical Conditioning, Animal / Q000502:physiology*; D011897:Random Allocation; D011965:Receptors, Glucocorticoid / Q000096:biosynthesis / Q000502:physiology*
D001786:Blood Glucose; D005938:Glucocorticoids; D007328:Insulin; D011965:Receptors, Glucocorticoid; D042842:11-beta-Hydroxysteroid Dehydrogenases